Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Hi,
I have an opportunity to buy some common shares. Last round was in August at 2.00 USD per unit (1 common share plus 1/2 warrant).
Anyone care to offer an opinion on the current value of the common shares (or the warrants)?
-Michael